Development of the Virtual Unified Huntington's Disease Rating Scale
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jody Goldstein
Huntington Study Group
Study Director - Samuel Frank, MD
Huntington Study Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham, Department of Neurology
Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- University of California, San Diego
La Jolla, California, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- University of South Florida, Huntington Disease Center of Excellence
Tampa, Florida, United States
- Northwestern University Medical Center, Department of Neurology
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Indiana University School of Medicine
Indianapolis, Indiana, United States
- Hereditary Neurological Disease Center
Wichita, Kansas, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Massachusetts General Hospital
Charlestown, Massachusetts, United States
- Washington University
St Louis, Missouri, United States
- Sanford Brain and Spine Clinic
Fargo, North Dakota, United States
- Ohio State University Medical Center
Columbus, Ohio, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- University of Texas, Health Science Center
Houston, Texas, United States
- University of Vermont Medical Center
Burlington, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Sept 2022
- Primary completion
- 2 May 2023
- Completion
- 2 May 2023
- Last update posted
- 28 Sept 2023
- Registered enrollment
- 60
- Registry id
- NCT05748288
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.